Hims vs Ro for Weight Loss: Which GLP-1 Provider Is Better?
An independent, side-by-side comparison of Hims and Ro for GLP-1 weight loss programs — pricing, medications, protocols, and patient experience.

Quick Verdict
Best Price
Ro
Starting at $149/mo vs $199/mo
Most Medications
Hims
2 medications vs 2
Best for Beginners
Hims
Async Telehealth, fast onboarding
Head-to-Head Comparison
Pricing Breakdown
Side-by-side pricing for every medication.
| Medication | Hims | Ro | Savings |
|---|---|---|---|
| Semaglutide | $199/monthly | $149/monthly | Save $50/mo with Ro |
| Tirzepatide | $399/monthly | $299/monthly | Save $100/mo with Ro |
Pros and Cons
Hims
- Publicly traded company with financial transparency
- Massive scale — millions of customers across health verticals
- Both compounded and brand-name options
- Free provider consultations included
- No video consultations
- No lab testing included
- GLP-1 only — no other peptides
- Compounded medication availability may vary by state
Ro
- Competitive compounded semaglutide pricing (from $149/mo)
- Large established platform with millions of patients
- Free ongoing provider messaging
- Body program includes metabolic health coaching
- No video consultations — async only
- No lab testing included
- Only offers GLP-1 weight loss medications
- Compounded medications not FDA-approved as finished products
How They Compare
Our editorial assessment across key dimensions.
In-Depth Comparison
By maria-torres · Last updated March 29, 2026
Hims vs Ro for Weight Loss: Which GLP-1 Provider Is Better?
March 2026 Update: Hims has exited compounding after settling with Novo Nordisk, and now operates as an authorized distributor of branded Wegovy only. Ro continues to offer compounded semaglutide alongside branded options. These are now fundamentally different business models competing in the same market. For patients transitioning from compounded medications, see our Switching Between GLP-1 Medications Guide.
Hims and Ro are the two largest direct-to-consumer telehealth platforms offering GLP-1 medications for weight loss. Both use an async-only model and ship medications to your door — but their models diverged sharply in 2026. Hims is now brand-only (FDA-approved Wegovy via Novo Nordisk partnership), while Ro continues to offer both compounded and brand-name options.
Here's how they compare across every factor that matters.
How do Hims and Ro compare on price?
This comparison has fundamentally changed. Hims no longer offers compounded semaglutide, so for cash-pay patients without insurance, Ro's $149/month compounded option is significantly cheaper than any branded alternative through Hims. For patients with insurance, both platforms can facilitate branded GLP-1 prescriptions at similar costs.
| Hims | Ro | |
|---|---|---|
| Compounded semaglutide | ❌ No longer offered | $149/mo |
| Brand Wegovy (injectable) | Insurance-dependent (Novo distributor) | Insurance-dependent |
| Brand Wegovy (oral) | Available via Novo deal | Not yet offered |
| Brand Zepbound (tirzepatide) | $399/mo | $399/mo |
| Consultation fee | Free | Free |
| Shipping | Free | Free |
What medications do Hims and Ro offer?
Hims and Ro now serve fundamentally different medication menus. Hims' pivot to brand-only eliminates the compounding safety concern entirely — every medication is FDA-approved. However, it also eliminates the most affordable cash-pay option. Ro still offers compounded semaglutide at $149/month for patients who want lower cost and accept the compounding trade-offs.
| Medication | Hims | Ro |
|---|---|---|
| Compounded semaglutide (injectable) | ❌ (exited Mar 2026) | ✅ |
| Brand Wegovy (injectable) | ✅ (authorized Novo distributor) | ✅ |
| Brand Wegovy (oral) | ✅ | ❌ |
| Brand Zepbound | ✅ | ✅ |
| Compounded tirzepatide | ❌ | ❌ |
How do Hims and Ro work?
Both platforms are async-only — neither offers video consultations or in-person visits.
Hims Weight Loss Protocol
- Complete an online health assessment
- A licensed provider reviews your information (typically within 24 hours)
- If approved, medication ships to your door with free shipping
- Communicate with your provider via unlimited async messaging
- Dose adjustments handled through the messaging platform
Ro Weight Loss Protocol
- Complete an online health assessment
- Provider review within 24 hours
- Prescription and medication shipped (3-5 business days)
- Unlimited provider messaging for ongoing care
- Metabolic health coaching included at no extra cost
What's Included Beyond Medication
| Feature | Hims | Ro |
|---|---|---|
| Provider messaging | Unlimited | Unlimited |
| Video consultations | ❌ | ❌ |
| Lab testing | ❌ | ❌ |
| Metabolic coaching | ❌ | ✅ |
| Insurance navigation | ❌ | ❌ |
Ro includes metabolic health coaching at no additional cost — a meaningful differentiator for patients who want guidance on diet, exercise, and sustainable habits alongside medication.
What is the background of Hims and Ro?
| Hims | Ro | |
|---|---|---|
| Founded | 2017 | 2017 |
| Patients served | Millions | 1+ million |
| Public company | Yes (NYSE: HIMS) | No (private) |
| Pharmacy model | 503B-registered partners | 503B-registered partners |
Hims is publicly traded, which means SEC-mandated financial disclosures and regulatory oversight. Ro is a well-funded private company. Both are established platforms with large patient bases.
What are the pros and cons of Hims vs Ro?
Hims
Pros:
- Brand-only model — all medications are FDA-approved, eliminating compounding safety concerns
- Authorized Novo Nordisk distributor — access to branded Wegovy (injectable and oral)
- Publicly traded with financial transparency (NYSE: HIMS)
- Massive scale and brand recognition
Cons:
- No compounded option — no affordable cash-pay alternative for uninsured patients
- Brand medications are significantly more expensive without insurance
- No metabolic coaching included
- No video consultations or lab testing
Ro
Pros:
- Compounded semaglutide at $149/mo — most affordable cash-pay GLP-1 option among major platforms
- Metabolic health coaching included at no extra cost
- Both compounded and brand-name options on one platform
- Eli Lilly collaboration for Zepbound access
Cons:
- Compounded medications carry regulatory uncertainty (FDA enforcement ongoing)
- No oral semaglutide option
- No video consultations or lab testing
- Weight regain risk after discontinuation (common to all GLP-1 providers)
Which should you choose: Hims or Ro?
When patients search "Hims vs Ro which is better," the honest answer is that it depends entirely on whether you have insurance — these two platforms now target different patient situations.
Choose Hims if:
- You have insurance or can afford brand pricing — Hims' brand-only model means FDA-approved medications with no compounding uncertainty
- You want oral Wegovy — Hims offers branded oral Wegovy via the Novo Nordisk partnership
- Public company accountability matters to you — SEC oversight provides an extra layer of transparency
- You prioritize safety and regulatory certainty over cost
Choose Ro if:
- Budget is the priority — $149/mo for compounded semaglutide is the most affordable option among major platforms, making it the cheapest way to get semaglutide online through a major telehealth provider
- You want coaching included — Metabolic health coaching at no extra cost adds real value
- You want flexibility — Ro offers both compounded and branded options, letting you choose based on budget and preference
- You're comfortable with compounded medications despite the evolving regulatory landscape
Summary Table
| Factor | Hims | Ro |
|---|---|---|
| Compounded semaglutide | ❌ (exited) | $149/mo |
| Brand Wegovy (oral) | ✅ (via Novo) | ❌ |
| Brand Zepbound | $399/mo | $399/mo |
| Metabolic coaching | ❌ | ✅ |
| Video consultations | ❌ | ❌ |
| Lab testing | ❌ | ❌ |
| Company type | Public (NYSE) | Private |
| Our rating | 3.8/5 | 4.0/5 |
Hims and Ro now serve different markets. Hims is the safer choice for patients with insurance or budget for branded medications — no compounding concerns, FDA-approved everything. Ro is the better choice for cost-conscious patients willing to use compounded medications, with the added bonus of included coaching. For cash-pay patients without insurance, Ro's $149/month compounded semaglutide is hard to beat — though patients should also consider orforglipron (FDA approval expected April 2026 at $149/month) as a branded alternative at a similar price point once available.
Frequently Asked Questions
Is Hims or Ro better for GLP-1 weight loss? It depends on your insurance situation. Hims is better for insured patients who want FDA-approved branded medications with no compounding concerns. Ro is better for cash-pay patients who want the lowest price ($149/mo compounded semaglutide) plus included metabolic coaching.
How do I get semaglutide without insurance through Hims or Ro? Hims no longer offers compounded semaglutide, so uninsured patients face full brand pricing (hundreds per month). Ro is the better option for patients without insurance, offering compounded semaglutide at $149/mo — no insurance required.
Does Ro include coaching with their GLP-1 program? Yes. Ro includes metabolic health coaching at no additional cost, which covers diet, exercise, and habit guidance alongside medication. Hims does not include any coaching.
Is Hims or Ro worth it compared to other platforms? Both are reliable platforms, but neither offers the clinical depth of providers like Mochi Health (video visits, dietitians) or the insurance expertise of Sequence. If you want the cheapest compounded semaglutide, Ro at $149/mo matches Henry Meds.
Can I get brand Wegovy through Ro? Yes. Ro offers both compounded and branded GLP-1 options, including Wegovy and Zepbound through insurance.
Does Hims offer any cash-pay GLP-1 option after exiting compounding? The most accessible cash-pay option through Hims is brand Zepbound at $399/mo. There is no $149–$199/mo tier available through Hims as of March 2026.
Related Resources
- Hims Weight Loss Review — Full Hims analysis
- Ro Weight Loss Review — Full Ro analysis
- Best GLP-1 Weight Loss Programs 2026 — All providers ranked
- GLP-1 Pricing Breakdown by Provider — Side-by-side cost comparison
- GLP-1 Cost & Insurance FAQ — What you'll actually pay
Related Guides
Aleniglipron: Structure Therapeutics' Oral GLP-1 — What Patients Need to Know
Complete guide to aleniglipron, Structure Therapeutics' investigational oral GLP-1 showing 16.3% placebo-adjusted weight loss at 44 weeks in Phase 2 ACCESS II — the highest weight loss reported for any oral GLP-1 to date. Only 3.7% discontinuation rate. Phase 3 expected H2 2026, with earliest FDA approval in 2028 or later.
Read guide →Best GLP-1 Options After Foundayo Approval: Oral vs Injectable 2026
Read guide →Best GLP-1 Weight Loss Programs 2026: Every Major Provider Ranked
Every major GLP-1 weight loss program ranked — real pricing, clinical models, and honest assessments. No provider paid for placement.
Read guide →